1
|
Ersoy B, Herzog ML, Pan W, Schilling S, Endres M, Göttert R, Kronenberg GD, Gertz K. The atypical antidepressant tianeptine confers neuroprotection against oxygen-glucose deprivation. Eur Arch Psychiatry Clin Neurosci 2024; 274:777-791. [PMID: 37653354 PMCID: PMC11127858 DOI: 10.1007/s00406-023-01685-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/17/2023] [Accepted: 08/14/2023] [Indexed: 09/02/2023]
Abstract
Proregenerative and neuroprotective effects of antidepressants are an important topic of inquiry in neuropsychiatric research. Oxygen-glucose deprivation (OGD) mimics key aspects of ischemic injury in vitro. Here, we studied the effects of 24-h pretreatment with serotonin (5-HT), citalopram (CIT), fluoxetine (FLU), and tianeptine (TIA) on primary mouse cortical neurons subjected to transient OGD. 5-HT (50 μM) significantly enhanced neuron viability as measured by MTT assay and reduced cell death and LDH release. CIT (10 μM) and FLU (1 μM) did not increase the effects of 5-HT and neither antidepressant conferred neuroprotection in the absence of supplemental 5-HT in serum-free cell culture medium. By contrast, pre-treatment with TIA (10 μM) resulted in robust neuroprotection, even in the absence of 5-HT. Furthermore, TIA inhibited mRNA transcription of candidate genes related to cell death and hypoxia and attenuated lipid peroxidation, a hallmark of neuronal injury. Finally, deep RNA sequencing of primary neurons subjected to OGD demonstrated that OGD induces many pathways relating to cell survival, the inflammation-immune response, synaptic dysregulation and apoptosis, and that TIA pretreatment counteracted these effects of OGD. In conclusion, this study highlights the comparative strength of the 5-HT independent neuroprotective effects of TIA and identifies the molecular pathways involved.
Collapse
Affiliation(s)
- Burcu Ersoy
- Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Center for Stroke Research Berlin, Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Berlin-Brandenburg School for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Marie-Louise Herzog
- Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Center for Stroke Research Berlin, Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- DZHK (German Center for Cardiovascular Research), Partner site, Berlin, Germany
| | - Wen Pan
- Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Center for Stroke Research Berlin, Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- DZHK (German Center for Cardiovascular Research), Partner site, Berlin, Germany
| | - Simone Schilling
- Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Center for Stroke Research Berlin, Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- DZHK (German Center for Cardiovascular Research), Partner site, Berlin, Germany
- Berlin Institute of Health at Charité, Universitätsmedizin Berlin, Berlin, Germany
| | - Matthias Endres
- Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Center for Stroke Research Berlin, Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- DZHK (German Center for Cardiovascular Research), Partner site, Berlin, Germany
- Einstein Center for Neurosciences, Charité-Universitätsmedizin Berlin, Berlin, Germany
- DZNE (German Center for Neurodegenerative Diseases), Partner site, Berlin, Germany
- DZPG (German Center for Mental Health), Partner site, Berlin, Germany
| | - Ria Göttert
- Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Center for Stroke Research Berlin, Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- DZHK (German Center for Cardiovascular Research), Partner site, Berlin, Germany
| | - Golo D Kronenberg
- Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zürich, Lenggstrasse 31, P.O. Box 363, 8032, Zurich, Switzerland
| | - Karen Gertz
- Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Center for Stroke Research Berlin, Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- DZHK (German Center for Cardiovascular Research), Partner site, Berlin, Germany.
- Einstein Center for Neurosciences, Charité-Universitätsmedizin Berlin, Berlin, Germany.
| |
Collapse
|
2
|
Garmanchuk LV, Yakovlev PG, Ostrovska GV, Stupak YA, Skachkova OV, Gorbach OI, Stepanov YV. COMPARISON OF 2D AND 3D PRIMARY CELL CULTURES OBTAINED FROM EXPLANT OF HIGH-GRADE UROTHELIAL BLADDER CANCER. Exp Oncol 2023; 45:130-136. [PMID: 37417273 DOI: 10.15407/exp-oncology.2023.01.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Indexed: 07/08/2023]
Abstract
Studying the biological characteristics of bladder cancer in primary culture can be an effective way for diagnostic and prognostic purposes, as well as choosing a scheme for personalized therapy. AIM To characterize and compare 2D and 3D primary cell cultures obtained from the same tumor sample resected from a patient with high-grade bladder cancer. MATERIALS AND METHODS 2D and 3D primary cell cultures were obtained from explants of resected bladder cancer. Glucose metabolism, lactate dehydrogenase (LDH) activity, and level of apoptosis were studied. RESULTS Multicellular tumor spheroids (3D) differ from planar culture (2D) by more pronounced consumption of glucose from the culture medium (1.7 times higher than 2D on Day 3 of culture), increased lactate dehydrogenase activity (2.5 times higher on Day 3 vs. Day 1 of cultivation, while in 2D culture LDH activity is constant), stronger acidification of the extracellular environment (pH dropped by 1 in 3D and by 0.5 in 2D). Spheroids demonstrate enhanced resistance to apoptosis (1.4 times higher). CONCLUSION This methodological technique can be used both for tumor characterization and for selection of optimal postoperative chemotherapeutic schemes.
Collapse
Affiliation(s)
- L V Garmanchuk
- Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine
| | - P G Yakovlev
- linical Hospital "Feofaniya", Center of Urology and Oncourology, Kyiv 03143, Ukraine
| | - G V Ostrovska
- Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine
| | - Yu A Stupak
- Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine
| | - O V Skachkova
- National Cancer Institute of Ukraine, Kyiv 03022, Ukraine
| | - O I Gorbach
- National Cancer Institute of Ukraine, Kyiv 03022, Ukraine
| | - Yu V Stepanov
- R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine
| |
Collapse
|
3
|
Yan C, Zhan M, Xv K, Zhang S, Liang T, Yu R. Sludge dewaterability enhancement under low temperature condition with cold-tolerant Bdellovibrio sp. CLL13. THE SCIENCE OF THE TOTAL ENVIRONMENT 2022; 820:153269. [PMID: 35074377 DOI: 10.1016/j.scitotenv.2022.153269] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/20/2021] [Revised: 01/04/2022] [Accepted: 01/15/2022] [Indexed: 06/14/2023]
Abstract
The dewatering performance of waste activated sludge (WAS) is generally deteriorated under low temperature due to the increase of viscosity, which would exacerbate the difficulties in sludge treatment and disposal. In this study, the cold-tolerant Bdellovibrio sp. CLL13 was successfully screened for efficient sludge biolysis, and it dramatically improved the sludge dewaterability while no significant biolysis effects were observed for the mesophilic BALO strain at 12 °C. The reduction rates of the sludge capillary suction time (CST), the specific resistance of filtration (SRF), the sludge dry weight, and the fecal coliform bacteria concentration at the optimal reaction time of 14 h were 40.1 ± 0.2%, 69.6 ± 0.7%, 7.7 ± 0.4%, and 78.5 ± 0.4%, respectively, when the mixed liquid suspended solids (MLSS) content was between 10.8 and 29.6 g/L, the input dosage of CLL13 was 8.8 × 106 PFU/mL sludge, and the DO level was 1.2 mg/L. Meanwhile, the viscosity reduction rate, the relative hydrophobicity increasement rate, and the bound water reduction rate were 20.3 ± 1.2%, 6.9 ± 0.7%, and 29.4 ± 1.0%, respectively. The ratios of protein content to polysaccharides content in the extracellular polymeric substances (EPS) decreased significantly. In addition, the degradation of the macromolecular substances in EPS and the increase of the soluble chemical oxygen demand, the total nitrogen, the total phosphorus, and the lactate dehydrogenase levels were observed. Therefore, the cold-tolerant CLL13 induced the sludge biolysis and compromised the negative effects of low temperature on the sludge dewatering performance, which should be beneficial for the efficient WAS biolysis treatment application in the near future under low temperature.
Collapse
Affiliation(s)
- Chunhui Yan
- Department of Environmental Science and Engineering, School of Energy and Environment, Southeast University, Nanjing 210096, China
| | - Manjun Zhan
- Nanjing Research Institute of Environmental Protection, Nanjing Environmental Protection Bureau, Nanjing 210013, Jiangsu, China
| | - Kewei Xv
- Wuxi Xishan Water Group Co., Ltd., Wuxi 214101, Jiangsu, China
| | - Siyuan Zhang
- Department of Environmental Science and Engineering, School of Energy and Environment, Southeast University, Nanjing 210096, China
| | - Ting Liang
- Wuxi Xishan Water Group Co., Ltd., Wuxi 214101, Jiangsu, China
| | - Ran Yu
- Department of Environmental Science and Engineering, School of Energy and Environment, Southeast University, Nanjing 210096, China.
| |
Collapse
|
4
|
Amunugama K, Pike DP, Ford DA. E. coli strain-dependent lipid alterations in cocultures with endothelial cells and neutrophils modeling sepsis. Front Physiol 2022; 13:980460. [PMID: 36203941 PMCID: PMC9530349 DOI: 10.3389/fphys.2022.980460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2022] [Accepted: 08/30/2022] [Indexed: 11/30/2022] Open
Abstract
Dysregulated lipid metabolism is common in infection and inflammation and is a part of the complex milieu underlying the pathophysiological sequelae of disease. Sepsis is a major cause of mortality and morbidity in the world and is characterized by an exaggerated host response to an infection. Metabolic changes, including alterations in lipid metabolism, likely are important in sepsis pathophysiology. Here, we designed an in vitro cell culture model using endothelial cells, E. coli, and neutrophils to mimic sepsis in a simplified cell model. Lipid alterations were studied in the presence of the pathogenic E. coli strain CFT073 and non-pathogenic E. coli strain JM109. We employed untargeted lipidomics to first identify lipid changes and then targeted lipidomics to confirm changes. Both unique and shared lipid signatures were identified in cocultures with these E. coli strains. In the absence of neutrophils, the CFT073 strain elicited alterations in lysophosphatidylcholine and diglyceride molecular species during coculture while both strains led to increases in phosphatidylglycerols. Lipid alterations in these cocultures changed with the addition of neutrophils. In the presence of neutrophils with E. coli and endothelial cells, triglyceride increases were a unique response to the CFT073 strain while phosphatidylglycerol and diglyceride increases occurred in response to both strains. Phosphatidylethanolamine also increased in neutrophils, E. coli and endothelial cells cocultures, and this response was greater in the presence of the CFT073 strain. We further evaluated changes in phosphatidylethanolamine in a rat model of sepsis, which showed multiple plasma phosphatidylethanolamine molecular species were elevated shortly after the induction of sepsis. Collectively, these findings demonstrate unique lipid responses by co-cultures of E. coli with endothelial cells which are dependent on the E. coli strain as well as the presence of neutrophils. Furthermore, increases in phosphatidylethanolamine levels in CFT073 urosepsis E. coli, endothelial cell, neutrophil cocultures were similarly observed in the plasma of septic rats.
Collapse
Affiliation(s)
- Kaushalya Amunugama
- Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, United States.,Center for Cardiovascular Research, Saint Louis University School of Medicine, St. Louis, MO, United States
| | - Daniel P Pike
- Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, United States.,Center for Cardiovascular Research, Saint Louis University School of Medicine, St. Louis, MO, United States
| | - David A Ford
- Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, United States.,Center for Cardiovascular Research, Saint Louis University School of Medicine, St. Louis, MO, United States
| |
Collapse
|
5
|
Agrahari AK, Singh AK, Singh AS, Singh M, Maji P, Yadav S, Rajkhowa S, Prakash P, Tiwari VK. Click inspired synthesis of p-tert-butyl calix[4]arene tethered benzotriazolyl dendrimers and their evaluation as anti-bacterial and anti-biofilm agents. NEW J CHEM 2020. [DOI: 10.1039/d0nj02591g] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
CuAAC inspired calix-[4]arene tethered benzotriazolyl dendrimers were developed and investigated for their therapeutic potential, where 7 displayed potent anti-bacterial and anti-biofilm activities against drug-resistant & slime producing organisms.
Collapse
Affiliation(s)
- Anand K. Agrahari
- Department of Chemistry
- Centre of Advanced Study
- Institute of Science
- Banaras Hindu University
- Varanasi-221005
| | - Ashish K. Singh
- Bacterial Biofilm and Drug Resistance Research Laboratory
- Department of Microbiology, Institute of Medical Sciences
- Banaras Hindu University
- Varanasi-221005
- India
| | - Anoop S. Singh
- Department of Chemistry
- Centre of Advanced Study
- Institute of Science
- Banaras Hindu University
- Varanasi-221005
| | - Mala Singh
- Department of Chemistry
- Centre of Advanced Study
- Institute of Science
- Banaras Hindu University
- Varanasi-221005
| | - Pathik Maji
- Department of Chemistry
- Guru Ghasidas University
- Bilaspur-495009
- India
| | - Shivangi Yadav
- Bacterial Biofilm and Drug Resistance Research Laboratory
- Department of Microbiology, Institute of Medical Sciences
- Banaras Hindu University
- Varanasi-221005
- India
| | - Sanchayita Rajkhowa
- Department of Chemistry
- Jorhat Institute of Science and Technology
- Jorhat-785010
- India
| | - Pradyot Prakash
- Bacterial Biofilm and Drug Resistance Research Laboratory
- Department of Microbiology, Institute of Medical Sciences
- Banaras Hindu University
- Varanasi-221005
- India
| | - Vinod K. Tiwari
- Department of Chemistry
- Centre of Advanced Study
- Institute of Science
- Banaras Hindu University
- Varanasi-221005
| |
Collapse
|
6
|
Singh AK, Mishra H, Firdaus Z, Yadav S, Aditi P, Nandy N, Sharma K, Bose P, Pandey AK, Chauhan BS, Neogi K, Vikram K, Srivastava A, Kar AG, Prakash P. MoS 2-Modified Curcumin Nanostructures: The Novel Theranostic Hybrid Having Potent Antibacterial and Antibiofilm Activities against Multidrug-Resistant Hypervirulent Klebsiella pneumoniae. Chem Res Toxicol 2019; 32:1599-1618. [PMID: 31315397 DOI: 10.1021/acs.chemrestox.9b00135] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The recent emergence of hypervirulent clinical variants of Klebsiella pneumoniae (hvKP) causing community-acquired, invasive, metastatic, life-threatening infections of lungs, pleura, prostate, bones, joints, kidneys, spleen, muscles, soft-tissues, skin, eyes, central nervous system (CNS) including extrahepatic abscesses, and primary bacteremia even in healthy individuals has posed stern challenges before the existing treatment modalities. There is therefore an urgent need to look for specific and effective therapeutic alternatives against the said bacterial infection or recurrence. A new type of MoS2-modified curcumin nanostructure has been developed and evaluated as a potential alternative for the treatment of multidrug-resistant isolates. The curcumin quantum particles have been fabricated with MoS2 via a seed-mediated hydrothermal method, and the resulting MoS2-modified curcumin nanostructures (MQCs) have been subsequently tested for their antibacterial and antibiofilm properties against hypervirulent multidrug-resistant Klebsiella pneumoniae isolates. In the present study, we found MQCs inhibiting the bacterial growth at a minimal concentration of 0.0156 μg/mL, while complete inhibition of bacterial growth was evinced at concentration 0.125 μg/mL. Besides, we also investigated their biocompatibility both in vitro and in vivo. MQCs were found to be nontoxic to the SiHa cells at a dose as high as 1024 μg/mL on the basis of the tested adhesion, spreading of the cells, and also on the various serological, biochemical, and histological investigations of the vital organs and blood of the Charles Foster Rat. These results suggest that MQCs have potent antimicrobial activities against hvKP and other drug resistant isolates and therefore may be used as broad spectrum antibacterial and antibiofilm agents.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | - Kunwar Vikram
- Department of Physics , Indian Institutes of Sciences , Bangalore 560012 , India.,Graphic Era University , Dehradun 248002 , India
| | | | | | | |
Collapse
|
7
|
Jochner MCE, An J, Lättig-Tünnemann G, Kirchner M, Dagane A, Dittmar G, Dirnagl U, Eickholt BJ, Harms C. Unique properties of PTEN-L contribute to neuroprotection in response to ischemic-like stress. Sci Rep 2019; 9:3183. [PMID: 30816308 PMCID: PMC6395706 DOI: 10.1038/s41598-019-39438-1] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2018] [Accepted: 12/14/2018] [Indexed: 12/18/2022] Open
Abstract
Phosphatase and tensin homolog (PTEN) signalling might influence neuronal survival after brain ischemia. However, the influence of the less studied longer variant termed PTEN-L (or PTENα) has not been studied to date. Therefore, we examined the translational variant PTEN-L in the context of neuronal survival. We identified PTEN-L by proteomics in murine neuronal cultures and brain lysates and established a novel model to analyse PTEN or PTEN-L variants independently in vitro while avoiding overexpression. We found that PTEN-L, unlike PTEN, localises predominantly in the cytosol and translocates to the nucleus 10-20 minutes after glutamate stress. Genomic ablation of PTEN and PTEN-L increased neuronal susceptibility to oxygen-glucose deprivation. This effect was rescued by expression of either PTEN-L indicating that both PTEN isoforms might contribute to a neuroprotective response. However, in direct comparison, PTEN-L replaced neurons were protected against ischemic-like stress compared to neurons expressing PTEN. Neurons expressing strictly nuclear PTEN-L NLS showed increased vulnerability, indicating that nuclear PTEN-L alone is not sufficient in protecting against stress. We identified mutually exclusive binding partners of PTEN-L or PTEN in cytosolic or nuclear fractions, which were regulated after ischemic-like stress. GRB2-associated-binding protein 2, which is known to interact with phosphoinositol-3-kinase, was enriched specifically with PTEN-L in the cytosol in proximity to the plasma membrane and their interaction was lost after glutamate exposure. The present study revealed that PTEN and PTEN-L have distinct functions in response to stress and might be involved in different mechanisms of neuroprotection.
Collapse
Affiliation(s)
- Magdalena C E Jochner
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Neurocure Cluster of Excellence, Department of Experimental Neurology, Berlin, Germany
- Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Berlin Institute of Health (BIH), QUEST-Centre for Transforming Biomedical Research, 10178 Berlin, Germany
| | - Junfeng An
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Neurocure Cluster of Excellence, Department of Experimental Neurology, Berlin, Germany
- Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Medical Research Centre, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Gisela Lättig-Tünnemann
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Neurocure Cluster of Excellence, Department of Experimental Neurology, Berlin, Germany
- Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Marieluise Kirchner
- Max Delbrück Centre for Molecular Medicine (MDC), Proteomics Platform, Robert-Rössle-Straße 10, 13125, Berlin, Germany
- Berlin Institute of Health (BIH), Proteomics Platform, 10178 Berlin, Germany
| | - Alina Dagane
- Max Delbrück Centre for Molecular Medicine (MDC), Proteomics Platform, Robert-Rössle-Straße 10, 13125, Berlin, Germany
| | - Gunnar Dittmar
- Max Delbrück Centre for Molecular Medicine (MDC), Proteomics Platform, Robert-Rössle-Straße 10, 13125, Berlin, Germany
- Proteome and Genome Research Laboratory, Luxembourg institute of Health, 1a Rue Thomas Edison, 1224, Strassen, Luxembourg
| | - Ulrich Dirnagl
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Neurocure Cluster of Excellence, Department of Experimental Neurology, Berlin, Germany
- Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Berlin Institute of Health (BIH), QUEST-Centre for Transforming Biomedical Research, 10178 Berlin, Germany
- German Centre for Neurodegenerative Diseases (DZNE), Berlin, Germany
- Charité-Universitätsmedizin Berlin, Institute of Biochemistry, Berlin, Germany
| | - Britta J Eickholt
- Charité-Universitätsmedizin Berlin, Institute of Biochemistry, Berlin, Germany
| | - Christoph Harms
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Neurocure Cluster of Excellence, Department of Experimental Neurology, Berlin, Germany.
- Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Berlin Institute of Health (BIH), QUEST-Centre for Transforming Biomedical Research, 10178 Berlin, Germany.
| |
Collapse
|
8
|
Baidukova O, Wang Q, Chaiwaree S, Freyer D, Prapan A, Georgieva R, Zhao L, Bäumler H. Antioxidative protection of haemoglobin microparticles (HbMPs) by PolyDopamine. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 2018; 46:S693-S701. [PMID: 30450978 DOI: 10.1080/21691401.2018.1505748] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
Clinically applicable haemoglobin-based oxygen carriers (HBOCs) should neither induce immunological nor toxic reactions. Additionally, Hb should be protected against oxidation. In the absence of protective enzymes (superoxide dismutase (SOD) and catalase (CAT)) Hb is oxidized to MetHb and thus losing its function of oxygen delivery. Alternatively, polydopamine (PD), a scavenger of free radicals, could be used for Hb protection against oxidation Therefore, we synthetized HbMPs modified with PD. The content of functional haemoglobin in these PD-HbMPs was twice higher than that in the control HbMPs due to the protective antioxidant effect of PD. In addition, the PD-HbMPs exhibited a high scavenging activity of free radicals including H2O2 and excellent biocompatibility. In contrast to monomeric dopamine, which has been shown to produce toxic effects on neurons due to formation of H2O2, hydroxyl radicals and superoxide during the process of auto-oxidation, PD-HbMPs are not neurotoxic. Consequently, the results presented here suggest a great potential of PD-HbMPs as HBOCs.
Collapse
Affiliation(s)
- Olga Baidukova
- a Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine , Berlin , Germany
| | - Quan Wang
- a Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine , Berlin , Germany.,b Institute of Health Service and Transfusion Medicine , Bejing , PR China
| | - Saranya Chaiwaree
- a Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine , Berlin , Germany.,c Faculty of Pharmacy , Payap University , Chiang Mai , Thailand
| | - Dorette Freyer
- d Department of Experimental Neurology, Clinic of Neurology , Charité-Universitätsmedizin Berlin , Berlin , Germany
| | - Ausanai Prapan
- a Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine , Berlin , Germany.,e Department of Radiological Technology , Naresuan University , Phitsanulok , Thailand
| | - Radostina Georgieva
- a Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine , Berlin , Germany.,f Medical Faculty, Department of Medical Physics, Biophysics, and Radiology , Trakia Unversity , Stara Zagora , Bulgaria
| | - Lian Zhao
- b Institute of Health Service and Transfusion Medicine , Bejing , PR China
| | - Hans Bäumler
- a Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine , Berlin , Germany
| |
Collapse
|